We present an overview of computational approaches for the prediction of metabolic pathways by which plants biosynthesise compounds, with a focus on selected very promising anticancer secondary metabolites from floral sources. We also provide an overview of databases for the retrieval of useful genomic data, discussing the strengths and limitations of selected prediction software and the main computational tools (and methods), which could be employed for the investigation of the uncharted routes towards the biosynthesis of some of the identified anticancer metabolites from plant sources, eventually using specific examples to address some knowledge gaps when using these approaches.
Introduction
An immense number of secondary metabolites (SMs) exist in nature, originating from plants, bacteria, fungi and marine life forms, serving as drugs for the treatment of many life-threatening diseases, including cancer [1] [2] [3] [4] . Taxol, vinblastine, vincristine, podophyllotoxin and camptothecin, for example, are typically well-known drugs used in cancer treatment, which are of plant origin. The search for drugs against cancer has often resorted to plants and marine life for lead compounds. To illustrate this, Newmann and Cragg published a recent study in which it was shown that ~49% of drugs used in cancer treatment were either natural products
The four main strategies that are mostly employed to identify such pathways are based on processes involved in the production of plant secondary metabolites, for example, physical clustering, co-expression, evolutionary co-occurrence and epigenomic co-regulation of the genes [22] [23] [24] [25] . Such approaches have been successfully applied for the investigation of fungal and microbial metabolites [26] [27] [28] . Since the discovery of the first gene cluster for secondary metabolism in Zea mays, the corn species [29] , BGCs for plant secondary metabolism have become an emerging theme in plant biology [30] . It is even believed that synthetic biology technologies will eventually lead to the effective functional reconstitution of candidate pathways using a variety of genetic systems [25] . A knowledge of BGCs and their manipulation is therefore important in understanding how to activate a number of 'silent' gene clusters observed from the investigation of whole-genome sequencing of organisms. This would make available a wealth of new chemical entities (NCEs), which could be evaluated as drug leads and biologically active compounds [20] .
This chapter aims at discussing the metabolic pathways by which plants biosynthesise compounds with anticancer activities, with a focus on selected very promising anticancer SMs from the African flora. We also aim to provide an overview of computational tools, which have been used to predict metabolic pathways and eventually address knowledge gaps when using the former. Additionally, we will present some databases for the retrieval of useful genomic data, discuss the strengths and limitations of selected computational (prediction) tools, which could be employed for the investigation of the uncharted routes towards the biosynthesis of some of the identified anticancer metabolites from plant sources, with specific examples. It is believed that properly addressing knowledge gaps that exist would lay the foundation for proper future investigations.
Natural products and plant genomic data
Genome data mining indicates that the vast majority of plant-based NPs have not yet been discovered [24, 25] . In addition, SMs are normally produced only at later growth stages of plant metabolism and are frequently found only at low concentrations within complex mixtures in plant extracts, due to several factors. Some of these factors include physiological variations, geographic variations, environmental conditions and genetic factors [25, 31, 32] . The aforementioned factors are the main drawbacks in the isolation and purification of NPs in meaningful quantities for either research or commercial aims. Nowadays, BGCs can be investigated using computational methodologies and used to predict the NPs present in microbial, fungal and floral matter [18, 20, 33, 34] . It is current knowledge that more than 70 genome sequences for several plant species have been made available, along with a wealth of transcriptome data [25] . However, the interpretation of such data, for example, the translation of predicted sequences into enzymes, pathways and SMs remains challenging. Advances in bioinformatics and synthetic biology have permitted the cheap and efficient overproduction of secondary metabolites of medicinal interest in heterologous (non-native) host organisms by reengineering of BGCs [35] . This is carried out through reengineering of BGCs as well as the activation of silent BGCs to yield unreported natural products of the target chemical space [17, 36] , for example, an engineered Escherichia coli strain was used as the heterologous host organism for the production of taxadiene (a vital precursor of paclitaxel, an anticancer agent isolated from the bark of Taxus brevifolia), a precursor of the anticancer agent taxol [37] .
In this way, quite a number of interesting SMs of plant origin (e.g. resveratrol, vanillin, conolidin, etc.) have been objects of pathway engineering in bacteria, yeast and other plants [38] . Thus, chemical libraries of diverse and novel hybrid natural products analogues can now be generated through combinatorial biosynthesis by manipulation of biosynthetic enzymes [39] , for example, several analogues of the antibiotic erythromycin were obtained via combinatorial biosynthesis [40] . Such bioengineered libraries of 'unnatural' natural products show promises in drug discovery campaigns against multidrug-resistant cancer cells.
Some database resources for retrieving secondary metabolism prediction information
A summary of databases for retrieving information on BGCs is provided in Table 1 . A majority of them focus on microbial BGCs, for example, ClusterMine360, ClustScan, DoBISCUIT, IMG-ABC and the Recombinant ClustScan Database. Details on the utility of the aforementioned databases have been provided in excellent recent reviews [26] [27] [28] 53] . Further efforts towards the construction of plant-based BGC and genomic databases include those of the Medicinal Plants Genomics and Metabolomics Resource consortium [47] . This effort has been focused on 14 medicinal plants and includes a BLAST search module, a genome browser, a genome putative search function tool and transcriptome search tools. While the entire database is available for download, similar efforts from the Plant Metabolic Network (PMN) have the advantage of having included several plant metabolic pathway databases, mostly among food crops [49, 50] . The PMN, for example, currently houses one multi-species reference database called PlantCyc and 22 species/taxon-specific databases, providing access to manually curated and/or computationally predicted information about enzymes, pathways, and more for individual species. 
Some computational tools for the analysis of genomic data and specialised metabolism prediction
Some computational tools for biochemical pathway prediction have been summarised in excellent reviews [54] . We have provided a more detailed summary of the main tools that could be useful in analysing plant and microbial genomic data for metabolism prediction in Table 2 . Some of the tools are designed for the detection and analysis of specialised metabolism in microbes (e.g. antiSMASH, CompGen, GNP, PRISM and WebAUGUSTUS). Others are specially designed for plant metabolism prediction or may only include data for some specific organisms (e.g. AraNet, MADIBA, miP3v2, PlantClusterFinder, SAVI and WikiPathways for plants), while others are more general tools, useful for both microbial and plant metabolism prediction and BGC analysis (e.g. E-zyme, KEGG, PathPred and PathComp) and others are more useful for developers (e.g. Geneious, OptFlux, PathVisio and Pathway GeneSWAPPER), 
thaliana. It is based on a modified
Bayesian integration of data from multiple organisms, each data type being weighted based on how well it links genes that are known to function together in A. thaliana. Each interaction is associated with a log-likelihood score (LLS), which is a measure of the probability of an interaction representing a true functional linkage between two genes [56] . On the other hand, MADIBA facilitates the interpretation of Plasmodium and plant (data currently available for Oryza sativa and A. thaliana) gene clusters [64] . This tool eases the task by automating the post-processing stage during the assignment of biological meaning to gene expression clusters. MADIBA is designed as a relational database and has stored data from gene to pathway for the aforementioned species. Tools within the GUI allow the rapid analyses of each cluster with the view of identifying the Gene Ontology terms, as well as visualising the metabolic pathways where the genes are implicated, their genomic localisations, putative common Designed for analysis of BGCs in microbes.
[55]
AraNet Gene function identification and genetic dissection of plant traits.
http://www.functionalnet.
org/aranet/ Had greater precision than literaturebased protein interactions (21%) for 55% of tested genes. Is highly predictive for diverse biological pathways.
Applicability is limited to one species -A. thaliana.
[56]
BioCyc/CycSim/ MetaCyc
Online tools for genome-scale metabolic modelling. Table 2 . Summary of current computational tools which could be useful for the plant genomic data analysis.
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transcriptional regulatory elements in the upstream sequences, and an analysis specific to the organism being studied.
PlantClusterFinder, SAVI and WikiPathways for plants are all purpose tools designed to assist in the prediction of metabolic gene cluster from plant genomes, although WikiPathways for plants has currently included mostly data for rice and Arabidopsis sp. SAVI has the added advantage of offering the user the possibility of including pathway metadata (e.g. taxonomic distribution, key reactions, etc.) and offering the possibility to decide which pathway(s) to keep and which to remove or validate manually.
Some computational methods for efficient production and the de novo engineering of natural products
Two main areas for computational tools can be distinguished: on the one hand the rational modification of genomes for the production of molecules by host organisms, and on the other hand the modification or the de novo design of gene clusters for the biosynthesis of novel NPs.
For both genetic engineering approaches, the already known genomes of bacteria, fungi and more and more plants provide the basic datasets. A very important computational approach for a rational modification of NP-producing host organisms is the genome-scale metabolic modelling [77, 78] .
Automatic assignments of functional annotations of all genes in a genome are ideally proven by manual curation and enriched by current knowledge about the metabolic network of subjected organisms. The curated genomes are then applied to a complete automatic reconstruction of the metabolic pathways of the cell. These metabolic models are normally encoded in the Systems Biology Markup Language (SBML) and are compatible with various software tools, for example, Cytoscape [79] , which can be applied for static network analyses. For instance, missing enzymes (gaps) within the network become apparent by substrates that are not taken up or have not been produced by the cell, as well as products that are not consumed by other reactions and are not secreted from cell. The RAST annotation pipeline provides a full automatic server for predicting all gene functions and discovering new pathways in microbial genomes of bacteria [80] . Such models can then be used to predict the turnover rate of each reaction in a Flux Balance Analysis (FBA) [81] . Several tools have been built, which apply FBA to identify enzymes that should be either introduced or knocked-out in the organism to increase production rate in the host organisms. A widely used FBA package is the MATLAB-based COBRA Toolbox [82] . With CycSim [58] , BioMet [83] and FAME [84] powerful web-based FBA applications were published that do not require any software installation.
Within the last 10 years, FBA was applied to support numerous genetic engineering approaches, for example, for the determination of minimal media in Helicobacter pylori [85] , for growth rate predictions in Bacillus subtilis [86] or for the development of metabolic engineering strategies in Pseudomonas putida [87] . Based on FBA, it was possible to increase vanillin production in baker's yeast by twofold and enhance sesquiterpene production in the same species [88, 89] .
The rational modification of a given genome to design novel molecules needs a detailed understanding of the producing gene clusters. Well-studied gene clusters such as polyketide synthases consist of specific domain types that can be identified by trained hidden Markov models that are stored in related databases, for example, PFAM [90] . Gene cluster analysis tools such as antiSMASH [55, 91] or PRISM [71] analyse a given gene cluster to predict the specific domains and to describe the architecture of a gene cluster. However, the prediction of the structure of the resulting natural products is a difficult task because substrate recognition of active sites and the correct ordering of enzymatic reactions has to be predicted. If subjected enzymes are catalysing multiple substrates, the availability of each substrate has to be predicted. Most frequently, the automatic analysis of a cluster is based on the deduction of information from gene clusters similar to the queried one.
If well-annotated similar gene clusters do not exist, the prediction of the structure of the biosynthesised NP is challenging. With more and more knowledge about the structure of natural products and the encoding sequences, the relation between the composition of the active sites and substrate binding will be better understood. Existing algorithms are often based on machine-learning approaches and predict the correct substrates for a selected set of enzyme families [92] . For the prediction of NPs synthesised by non-ribosomal peptide synthetases, such a sequence-based prediction method is integrated in the related webserver NRPSpredictor2 [93] . Rational substitution of residues to generate novel molecules still requires a detailed manual analysis of the encoding gene cluster, and new software tools that propose mutations leading to novel molecules might accelerate this approach considerably in future.
Selected natural products with promising anticancer properties from African sources
Recent reviews on the anticancer potential of African flora have discussed the anticancer, cytotoxic, antiproferative and antitumour activities of about 500 NPs [9] [10] [11] [12] . In this section, we focus on the most promising (recent) results for anticancer SMs from African flora species Ocotea macrocarpa (Lauraceae), which showed antiproliferative activities against the A2780 ovarian cell line [95] . The known isolates included the butanolides; linderanolide B (8, PubChem CID: 53308122) and isolinderanolide (9, PubChem CID: 44576054). The anticancer activities showed IC 50 values of 2.57 (5), 1.98 (6), 1.67 (7), 2.43 (8) 
Case studies
In this section, we shall discuss specific examples of the investigation of biosynthesis of anticancer plant-based SMs by (computational) analysis of genomic data.
Biogenesis of several anticancer metabolites by Ocimum tenuiflorum (Lamiaceae)
Species from the genus Ocimum are well known for their high medicinal values and are therefore used to cure a variety of ailments in Ayurveda, an Indian system of medicine [97, 98] . About 30 SMs have been reported from the genus Ocimum, with a variety of biological properties [99] . Only 14 of these SMs belong to the five basic groups of compounds having a complete biosynthetic pathway information in the PMN database [49, 50] , thereby leaving us with ~15 medicinally relevant metabolites from Ocimum sp. with unknown pathways. This has prompted further investigation on SMs with uncharted biosynthetic pathways. Several bioactive SMs, including the anticancer compounds; apigenin ( were expressed and identified from analysis of genome data. These were validated by q-RT-PCR on the different studied tissues (e.g. roots, mature leaves, etc.) of five closely related species (e.g.
O. gratissimum, O. sacharicum, O. kilmund, Solanum lycopersicum and Vitis vinifera)
, which showed a high extent of urosolic acid-producing genes in young leaves. The other identified anticancer metabolites included eugenol and ursolic acid. As an example, the authors employed sequence search algorithms to search for the three enzymes of the three-step synthetic pathway of ursolic acid from squalene in the Tulsi genome. Each of these enzymes in Tulsi (squalene epoxidase, α-amyrin synthase and α-amyrin 2,8 monoxygenase) were queried from the PlantCyc database, starting from their protein sequences. The search for analogous enzymes in the model plants O. sativa japonica and A. thaliana, showed sequence identity covering from 50 to 80% of the query length. The whole genome and sequence analysis of O. tenuiflorum suggested that small amino acid changes at the functional sites of genes involved in metabolite synthesis pathways could confer special medicinal (particularly anticancer) properties to this herb.
Biosynthesis of the anticancer alkaloid noscapine by Papaver somniferum (Papaveraceae)
Noscapine (25, PubChem CID: 275196) is an antitumour phthalideisoquinoline alkaloid from opium poppy (Papaver somniferum, Papaveraceae). Compound 25 is known to bind stoichiometrically to tubulin, alters its conformation, affects microtubule assembly (promotes microtubule polymerisation), hence arresting metaphase and inducing apoptosis in many cell types [101] . It has been demonstrated that the compound has potent antitumour activity against solid murine lymphoid tumours (even when the drug was administered orally). This drug has also shown potency against human breast, ovarian and bladder tumours implanted in nude mice and in dividing human cells [102, 103] . Although the compound is water-soluble and absorbed after oral administration, its chemotherapeutic potential in human cancer could not be fully exploited for drug discovery projects because, like most SMs, this has been limited by the typically small amounts produced in the slow-growing plant species [104] . The quest to improve production levels of the NP is essential for drug discovery. However, such would require a proper understanding biological processes underlying the biosynthesis of this SM, known from isotope-labelling experiments to be derived from scoulerine since the 1960s [105] . Winzer et al. have carried out a transcriptomic analysis, with the aim of elucidating the biosynthetic pathway of this important metabolite for the improvement of its commercial production in both poppy and other systems [106] . The analysis of a high noscapine-producing poppy variety, HN1, showed the exclusive expression of 10 genes encoding five distinct enzyme classes, whereas five functionally characterised genes (BBE, TNMT, SaIR, SaIAT and T6ODM) were present in all three of the studied poppy varieties, respectively, rich in morphine, thebaine and noscapine (HM1, HN1 and HT1).
The authors analysed the expressed sequence tag (EST) abundance and discovered some previously uncharacterised genes expressed in HN1, which were completely absent from the other (HM1 and HT1) EST libraries. This led to the identification of the corresponding enzymes as three O-methyltransferases (PSMT1, PSMT2, PSMT3), four cytochrome P450s (CYP82X1, CYP82X2, CYP82Y1 and CYP719A21), an acetyltransferase (PSAT1), a carboxylesterase (PSCXE1) and a short-chain dehydrogenase/reductase (PSSDR1). Further analysis of an F2 mapping population, using HN1 and HM1 as parents, indicated that these genes are tightly linked in HN1. Moreover, bacterial artificial chromosome sequencing confirmed the existence of a complex BGC for plant alkaloids. Based on the knowledge derived from the investigation, the authors could make suggestions for the improved production of noscapine and related bioactive molecules by the molecular breeding of commercial poppy varieties or engineering of new production systems, for example, by virus-induced gene silencing, which resulted in the accumulation of pathway intermediates, thus allowing gene function to be linked to noscapine synthesis [104, 106] .
Biosynthesis of vinblastine and vincristine by Catharanthus roseus (Apocynaceae)
Vinblastine (26, PubChem CID: 13342) and vincristine (27, PubChem CID: 5978) are chemotherapy drugs used to treat a number of cancer types. These are among the >120 known terpenoid indole alkaloids from the medicinal plant C. roseus, also known as the Madagascar periwinkle [107] . Since these two very important anticancer compounds have only been produced in very low amounts in C. roseus, as opposed to the fairly high levels of several monomeric alkaloids (e.g. ajmalicine and serpentine) [108] , attempts to improve the yields of 
The way forward
The case studies show that the detailed computational analysis of the transcriptomic and metabolomic data of a plant species could reveal its metabolic capacity and hence help identify candidate genes involved in the biosynthesis of the important SMs it contains. Thus, modifying the plant genes could represent a premise for improving metabolite yield. It should be mentioned that other compounds from some of the aforementioned compound classes (Table 3) , from both floral and microbial sources, have shown promising anticancer activities [109] [110] [111] [112] [113] , e.g. isolinderanolide B (28, PubChem CID: 53308122) (Figure 3) , a butanolide from the stems of Cinnamomum subavenium (Lauraceae) had shown antiproliferative activity in T24 human bladder cancer cells by blocking cell cycle progression and inducing apoptosis [112] . In addition, subamolide B (29, PubChem CID: 16104907), another butanolide from this same species, is known to induce cytotoxicity in human cutaneous squamous cell carcinoma through mitochondrial and CHOP-dependent cell death pathways [113] . Meanwhile, obtusilactone B (30, PubChem CID: 101286261), from Machilus thunbergii (Lauraceae), is known to target barrier-to-autointegration factor to treat cancer [111] .
From the African flora, apart from the Lauraceae, Phyllanthaceae and Annonaceae, known to be rich in anticancer metabolites, the genus Tacca of the yam family (Dioscoreaceae) is known for the abundant presence of taccalonolides, which are microtubule stabilisers with clinical potential for cancer treatment [114] . Additionally, the genus Tamarix (e.g. T. aphylla 
Conclusions
It has been our intention in this chapter to provide a detailed overview of the important computational tools and resources for the analysis of plant genomic data and for the prediction of biosynthetic pathways in plants. We have taken a few case studies of anticancer SMs to illustrate this. Even though it is unclear how widespread plant genes are clusters, genes that encode the biosynthesis of several small plant SMs are well known, including the vital genes for the production of some highly potent anticancer drugs. With the use of the tools and databases described, along with the drop in the cost of whole genome sequencing in plant species, the future for the discovery of new plant-based anticancer metabolites would involve the identification of one or more genes or BGCs encoding the enzymes in the biosynthetic pathway for the target compound(s), followed by the co-expression analysis, also exploiting the knowledge of the chemical structure of the target compound, for the identification of other enzymes that might be involved in this pathway. As an example, the exploration of the pathway for podophyllotoxin biosynthesis by the use transcriptome mining in Podophyllum hexandrum led to the identification biosynthetic genes, 29 of which were combinatorially expressed in the tobacco plant (Nicotiana benthamiana), leading to the identification of six pathway enzymes, among which is oxoglutarate-dependent dioxygenase responsible for closing the core cyclohexane ring of the aryltetralin scaffold [115] . An alternative approach could be, if the metabolic pathway and nature of SMs are unknown, then the identified co-expressed genes encoding the enzymes for secondary metabolism could be subjected to untargeted metabolomics for the elucidation of unknown pathways and chemical structures. As an example, a single pathogen-induced P450 enzyme, CYP82C2, with a combination of untargeted metabolomics and co-expression analysis was used to uncover the complete biosynthetic pathway, which leads to the metabolite 4-hydroxyindole-3-carbonyl nitrile, previously unknown to Arabidopsis sp. This rare and hitherto unprecedented plant metabolite, with a cyanogenic functionality revealed a hidden capacity of Arabidopsis sp. for cyanogenic glucoside biosynthesis. This was confirmed by expressing 4-OH-ICN engineering biosynthetic enzymes in Saccharomyces cerevisiae and Nicotiana benthamiana, to reconstitute the complete pathway in vitro and in vivo, thus validating the functions of the enzymes involved in the pathway [116] .
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